Cited by 237MRI in cancer diagnosisBreast Lesions and CarcinomasBreast Cancer Treatment Studies

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Open access

Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., Wildberger, J. E.·2013·Insights into Imaging

DOI 10.1007/s13244-013-0219-yPMC PMC3609956

Open this paper in CoChat — free account Open PDF

Abstract

OBJECTIVES: This systematic review aimed to assess the role of magnetic resonance imaging (MRI) in evaluating residual disease extent and the ability to detect pathologic complete response (pCR) after neoadjuvant chemotherapy for invasive breast cancer. METHODS: PubMed, the Cochrane Library, MEDLINE, and Embase databases were searched for relevant studies published until 1 July 2012. After primary selection, two reviewers independently assessed the content of each eligible study using a standardised extraction form and pre-defined inclusion and exclusion criteria. RESULTS: A total of 35 eligible studies were selected. Correlation coefficients of residual tumour size assessed by MRI and pathology were good, with a median value of 0.698. Reported sensitivity, specificity, positive predictive value and negative predictive value for predicting pCR with MRI ranged from 25 to 100 %, 50-97 %, 47-73 % and 71-100 %, respectively. Both overestimation and underestimation were observed. MRI proved more accurate in determining residual disease than physical examination, mammography and ultrasound. Diagnostic accuracy of MRI after neoadjuvant chemotherapy could be influenced by treatment regimen and breast cancer subtype. CONCLUSIONS: Breast MRI accuracy for assessing residual disease after neoadjuvant chemotherapy is good and surpasses other diagnostic means. However, both overestimation and underestimation of residual disease extent could be observed. MAIN MESSAGES: • Breast MRI accuracy for assessing residual disease is good and surpasses other diagnostic means. • Correlation coefficients of residual tumour size assessed by MRI and pathology were considered good. • However, both overestimation and underestimation of residual disease were observed. • Diagnostic accuracy of MRI seems to be affected by treatment regimen and breast cancer subtype.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s13244-013-0219-y

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Detailed overview of study selectionCC BY-NC · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
Martin Bland, J., & Altman, D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90837-8 · Cited by 47,965
Diagnostic Accuracy of Mammography, Clinical Examination, US, and MR Imaging in Preoperative Assessment of Breast Cancer
Berg, W. A., Gutierrez, L., NessAiver, M. S., Carter, W. B., Bhargavan, M., Lewis, R. S., & Ioffe, O. B. (2004) · Radiology · doi:10.1148/radiol.2333031484 · Cited by 1,441
Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis
Mauri, D., Pavlidis, N., & Ioannidis, J. P. A. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji021 · Cited by 1,214
Individual and Combined Effects of Age, Breast Density, and Hormone Replacement Therapy Use on the Accuracy of Screening Mammography
Carney, P. A., Miglioretti, D. L., Yankaskas, B. C., Kerlikowske, K. M., Rosenberg, R., Rutter, C. M., Geller, B. M., Abraham, L., Taplin, S. H., Dignan, M., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00008 · Cited by 1,144
Overview of resistance to systemic therapy in patients with breast cancer
Gonzalez-Angulo, A. M., Morales-Vasquez, F., & Hortobagyi, G. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-74039-3_1 · Cited by 904
Locally Advanced Breast Cancer: MR Imaging for Prediction of Response to Neoadjuvant Chemotherapy—Results from ACRIN 6657/I-SPY TRIAL
Hylton, N. M., Blume, J. D., Bernreuter, W. K., Pisano, E. D., Rosen, M. A., Morris, E. A., Weatherall, P. T., Lehman, C. D., Newstead, G. M., Polin, S. M., et al. (2012) · Radiology · doi:10.1148/radiol.12110748 · Cited by 499
Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast Cancer
Yeh, E. D., Slanetz, P. J., Kopans, D. B., Rafferty, E. A., Georgian-Smith, D., Moy, L. P., Halpern, E. F., Moore, R. H., Kuter, I., & Taghian, A. G. (2005) · American Journal of Roentgenology · doi:10.2214/ajr.184.3.01840868 · Cited by 400
Accuracy of MR Imaging for Revealing Residual Breast Cancer in Patients Who Have Undergone Neoadjuvant Chemotherapy
Partridge, S. C., Gibbs, J., Lü, Y., Esserman, L. J., Sudilovsky, D., & Hylton, N. M. (2002) · American Journal of Roentgenology · doi:10.2214/ajr.179.5.1791193 · Cited by 337
Magnetic Resonance Imaging Response Monitoring of Breast Cancer During Neoadjuvant Chemotherapy: Relevance of Breast Cancer Subtype
Loo, C. E., Straver, M. E., Rodenhuis, S., Muller, S. H., Wesseling, J., Peeters, M.-J. T. F. D. V., & Gilhuijs, K. G. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.1258 · Cited by 303
Diffusion-weighted MR Imaging: Pretreatment Prediction of Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
Park, S. H., Moon, W. K., Cho, N., Song, I. C., Chang, J. M., Park, I.-A., Han, W., & Noh, D. (2010) · Radiology · doi:10.1148/radiol.10092021 · Cited by 280

Show all 56 references

Sorted by citations

Contrast-enhanced Mammography: State of the Art
Jochelson, M. S., & Lobbes, M. B. I. (2021) · Radiology · doi:10.1148/radiol.2021201948 · Cited by 353
Self-citation
Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival—Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL
Hylton, N. M., Gatsonis, C. A., Rosen, M. A., Lehman, C. D., Newitt, D. C., Partridge, S. C., Bernreuter, W. K., Pisano, E. D., Morris, E. A., Weatherall, P. T., et al. (2015) · Radiology · doi:10.1148/radiol.2015150013 · Cited by 278
Imaging Neoadjuvant Therapy Response in Breast Cancer
Fowler, A. M., Mankoff, D. A., & Joe, B. N. (2017) · Radiology · doi:10.1148/radiol.2017170180 · Cited by 244
Quality indicators in breast cancer care: An update from the EUSOMA working group
Biganzoli, L., Marotti, L., Hart, C. D., Cataliotti, L., Cutuli, B., Kühn, T., Mansel, R. E., Ponti, A., Poortmans, P. M., Regitnig, P., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.08.017 · Cited by 225
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016
Liedtke, C., & Thill, M. (2016) · Breast Care · doi:10.1159/000446941 · Cited by 188
Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study
Huang, Y., Zhu, T., Zhang, X., Li, W., Zheng, X., Cheng, M., Ji, F., Zhang, L., Yang, C., Wu, Z., et al. (2023) · eClinicalMedicine · doi:10.1016/j.eclinm.2023.101899 · Cited by 175
Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging
Iotti, V., Ravaioli, S., Vacondio, R., Coriani, C., Caffarri, S., Sghedoni, R., Nitrosi, A., Ragazzi, M., Gasparini, E., Masini, C., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-017-0899-1 · Cited by 148
Early Prediction and Evaluation of Breast Cancer Response to Neoadjuvant Chemotherapy Using Quantitative DCE-MRI
Tudorica, A., Oh, K. Y., Hui, J. Y. C., Roy, N. C., Troxell, M. L., Naik, A. M., Kemmer, K. A., Chen, Y., Holtorf, M. L., Afzal, A., et al. (2016) · Translational Oncology · doi:10.1016/j.tranon.2015.11.016 · Cited by 138
Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients
Goorts, B., van Nijnatten, T. J. A., de Munck, L., Moossdorff, M., Heuts, E. M., de Boer, M., Lobbes, M. B. I., & Smidt, M. L. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4155-2 · Cited by 134
Self-citation
Role of Imaging in Neoadjuvant Therapy for Breast Cancer
Dialani, V. M., Chadashvili, T., & Slanetz, P. J. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4403-9 · Cited by 133
Role of Magnetic Resonance Imaging in Detection of Pathologic Complete Remission in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy: A Meta-analysis
Gu, Y.-L., Pan, S.-M., Ren, J., Yang, Z.-X., & Jiang, G.-Q. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2016.12.010 · Cited by 128
Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy
Patel, B., Hilal, T., Covington, M. F., Zhang, N., Kosiorek, H., Lobbes, M. B. I., Northfelt, D., & Pockaj, B. A. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6413-x · Cited by 116
Self-citation
Contrast-enhanced Mammography: Current Applications and Future Directions
Ghaderi, K. F., Phillips, J., Perry, H., Lotfi, P., & Mehta, T. S. (2019) · Radiographics · doi:10.1148/rg.2019190079 · Cited by 115
Meta-analysis of agreement between MRI and pathologic breast tumour size after neoadjuvant chemotherapy
Marinovich, M. L., Macaskill, P., Irwig, L., Sardanelli, F., von Minckwitz, G., Mamounas, E. P., Brennan, M. E., Ciatto, S., & Houssami, N. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.473 · Cited by 108
MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
Weber, J. J., Jochelson, M. S., Eaton, A. A., Zabor, E. C., Barrio, A. V., Gemignani, M. L., Pilewskie, M. L., Zee, K. J. V., Morrow, M., & El-Tamer, M. B. (2017) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2017.08.027 · Cited by 105
Exploring breast cancer response prediction to neoadjuvant systemic therapy using MRI-based radiomics: A systematic review
Granzier, R. W. Y., van Nijnatten, T. J. A., Woodruff, H. C., Smidt, M. L., & Lobbes, M. B. I. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108736 · Cited by 98
Self-citation
Prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer using a deep learning (DL) method
Qu, Y., Zhu, H., Cao, K., Li, X., Ye, M., & Sun, Y. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13309 · Cited by 96
MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variability
Granzier, R. W. Y., Verbakel, N. M. H., Ibrahim, A., van Timmeren, J. E., van Nijnatten, T. J. A., Leijenaar, R. T. H., Lobbes, M. B. I., Smidt, M. L., & Woodruff, H. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-70940-z · Cited by 88
Self-citation
Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer
Vriens, B. E. P. J., de Vries, B., Lobbes, M. B. I., van Gastel, S. M., van den Berkmortel, F. W. P. J., Smilde, T. J., van Warmerdam, L. J. C., de Boer, M., van Spronsen, D. J., Smidt, M. L., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.10.010 · Cited by 85
Self-citation
ACR Appropriateness Criteria ® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer
Slanetz, P. J., Moy, L. P., Baron, P. L., diFlorio‐Alexander, R. M., Green, E. D., Heller, S. L., Holbrook, A. I., Lee, S., Lewin, A. A., Lourenço, A. P., et al. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.08.037 · Cited by 83
MRI-based response patterns during neoadjuvant chemotherapy can predict pathological (complete) response in patients with breast cancer
Goorts, B., Dreuning, K. M. A., Houwers, J. B., Kooreman, L. F. S., Boerma, E.-J. G., Mann, R. M., Lobbes, M. B. I., & Smidt, M. L. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0950-x · Cited by 83
Self-citation
Breast cancer resistance to chemotherapy: When should we suspect it and how can we prevent it?
Prihantono, P., & Faruk, M. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102793 · Cited by 84
Proton MR spectroscopy in the breast: Technical innovations and clinical applications
Fardanesh, R., Marino, M. A., Avendaño, D., Leithner, D., Pinker, K., & Thakur, S. B. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26700 · Cited by 79
Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy
Kim, S.-Y., Cho, N., Park, I.-A., Kwon, B. R., Shin, S. U., Kim, S. Y., Lee, S. H., Chang, J. M., & Moon, W. K. (2018) · Radiology · doi:10.1148/radiol.2018172868 · Cited by 78
Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)
Barra, F. R., Sobrinho, A. B., Barra, R. R., Magalhães, M. T., Aguiar, L. R., de Albuquerque, G. F. L., Costa, R. P., Farage, L., & Pratesi, R. (2018) · BioMed Research International · doi:10.1155/2018/8531916 · Cited by 75
Neoadjuvant Systemic Therapy in Breast Cancer: Association of Contrast-enhanced MR Imaging Findings, Diffusion-weighted Imaging Findings, and Tumor Subtype with Tumor Response
Santamaría, G., Bargalló, X., Fernández, P. L., Farrus, B., Caparrós, X., & Velasco, M. (2016) · Radiology · doi:10.1148/radiol.2016160176 · Cited by 71
Neoadjuvant chemotherapy in hormone receptor-positive/HER2-negative early breast cancer: When, why and what?
Torrisi, R., Marrazzo, E., Agostinetto, E., Sanctis, R. D., Losurdo, A., Masci, G., Tinterri, C., & Santoro, A. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103280 · Cited by 65
Applying a new quantitative global breast MRI feature analysis scheme to assess tumor response to chemotherapy
Aghaei, F., Tan, M., Hollingsworth, A. B., & Zheng, B. (2016) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25276 · Cited by 62
Tumor Biology Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer
Gentile, L. F., Plitas, G., Zabor, E. C., Stempel, M. M., Morrow, M., & Barrio, A. V. (2017) · Annals of Surgical Oncology · doi:10.1245/s10434-017-6085-y · Cited by 62
Contrast-enhanced mammography: what the radiologist needs to know
Neeter, L. M. F. H., Raat, H., de Alcântara, R. C., Robbe, Q., Smidt, M. L., Wildberger, J. E., & Lobbes, M. B. I. (2021) · BJR|Open · doi:10.1259/bjro.20210034 · Cited by 59
Self-citation
Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
Bufi, E., Belli, P., Costantini, M., Cipriani, A., Matteo, M. D., Bonatesta, A., Franceschini, G., Terribile, D. A., Mulè, A., Nardone, L., et al. (2015) · Clinical Breast Cancer · doi:10.1016/j.clbc.2015.02.002 · Cited by 58
Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial
Lee, H., Han, W., Kim, S., Cho, N., Kim, K.-E., Park, J. H., Ju, Y. W., Lee, E.-S., Lim, S.-J., Kim, J. H., et al. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05678-3 · Cited by 57
Magnetic resonance imaging: The evolution of breast imaging
Heywang-Köbrunner, S. H., Hacker, A., & Sedlacek, S. (2013) · The Breast · doi:10.1016/j.breast.2013.07.014 · Cited by 54
Predicting the response to neoadjuvant therapy for early-stage breast cancer: tumor-, blood-, and imaging-related biomarkers
Tan, W., Yang, M. W., Yang, H., Zhou, F., & Shen, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s174435 · Cited by 49
Role of the Intravoxel Incoherent Motion Diffusion Weighted Imaging in the Pre-treatment Prediction and Early Response Monitoring to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Che, S., Zhao, X., Ou, Y.-H., Li, J., Wang, M., Wu, B., & Zhou, C. (2016) · Medicine · doi:10.1097/md.0000000000002420 · Cited by 48
Diagnostic accuracy of MRI to evaluate tumour response and residual tumour size after neoadjuvant chemotherapy in breast cancer patients
Bouzón, A., Nebril, B. A., Soler, R., Iglesias, Á., Santiago, P., Mosquera, J., Calvo, L., Seoane‐Pillado, T., & García, A. (2016) · Radiology and Oncology · doi:10.1515/raon-2016-0007 · Cited by 47
Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy
Negrão, E. M. S., de Souza, J. A., Marques, E. F., & Bitencourt, A. G. V. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.108701 · Cited by 47
A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer
Mao, N., Dai, Y., Zhou, H., Lin, F., Zheng, T., Li, Z., Yang, P., Zhao, F., Li, Q., Wang, W., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1576 · Cited by 51
“MRI is superior to mammography and US in determining tumor extent and morphology before and after NAC because it provides comprehensive imaging information about tumors ( 6 ).”
The Way of the Future: Personalizing Treatment Plans Through Technology
Liefaard, M. C., Lips, E. H., Wesseling, J., Hylton, N. M., Lou, B., Mansi, T., & Pusztai, L. (2021) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_320593 · Cited by 48
Contrast-enhanced MRI after neoadjuvant chemotherapy of breast cancer: lesion-to-background parenchymal signal enhancement ratio for discriminating pathological complete response from minimal residual tumour
Kim, S., Cho, N., Shin, S. U., Lee, H., Han, W., Park, I. A., Kwon, B. R., Kim, S., Lee, S. H., Chang, J. M., et al. (2018) · European Radiology · doi:10.1007/s00330-017-5251-8 · Cited by 43
Ultrasonography-Guided Surgical Clip Placement for Tumor Localization in Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer
Youn, I., Choi, S. H., Kook, S. H., Choi, Y. J., Park, C. H., Park, Y. L., & Kim, D. (2015) · Journal of Breast Cancer · doi:10.4048/jbc.2015.18.1.44 · Cited by 42
Molecular imaging of breast cancer: present and future directions
Alcántara, D., Leal, M. P., GarcÃa-Bocanegra, I., & García‐Martín, M. L. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00112 · Cited by 43
Hybrid 18F–FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy
Goorts, B., Vöö, S. A., van Nijnatten, T. J. A., Kooreman, L. F. S., de Boer, M., Keymeulen, K., Aarnoutse, R., Wildberger, J. E., Mottaghy, F. M., Lobbes, M. B. I., et al. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3745-x · Cited by 41
Self-citation
Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients
Cho, G. Y., Gennaro, L., Sutton, E. J., Zabor, E. C., Zhang, Z., Giri, D. D., Moy, L. P., Sodickson, D. K., Morris, E. A., Sigmund, E. E., et al. (2017) · European Journal of Radiology Open · doi:10.1016/j.ejro.2017.07.002 · Cited by 41
Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
Bufi, E., Belli, P., Matteo, M. D., Terribile, D. A., Franceschini, G., Nardone, L., Petrone, G., & Bonomo, L. (2014) · European Journal of Radiology · doi:10.1016/j.ejrad.2014.05.002 · Cited by 40
MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study
Granzier, R. W. Y., Ibrahim, A., Primakov, S. P., Samiei, S., van Nijnatten, T. J. A., de Boer, M., Heuts, E. M., Hulsmans, F. J., Chatterjee, A., Lambin, P., et al. (2021) · Cancers · doi:10.3390/cancers13102447 · Cited by 39
Self-citation
Prediction of pathologic complete response on MRI in patients with breast cancer receiving neoadjuvant chemotherapy according to molecular subtypes
Kim, J., Han, B., Ko, E. Y., Ko, E. S., Choi, J. S., & Park, K. W. (2022) · European Radiology · doi:10.1007/s00330-021-08461-0 · Cited by 39
Treatment Response Evaluation of Breast Cancer after Neoadjuvant Chemotherapy and Usefulness of the Imaging Parameters of MRI and PET/CT
An, Y. Y., Kim, S. H., Kang, B. J., & Lee, A. (2015) · Journal of Korean Medical Science · doi:10.3346/jkms.2015.30.6.808 · Cited by 39
Neoadjuvant approach in patients with early breast cancer: patient assessment, staging, and planning
Rubio, I. T., & Sobrido, C. (2021) · The Breast · doi:10.1016/j.breast.2021.12.019 · Cited by 36
Prediction of Tumor Shrinkage Pattern to Neoadjuvant Chemotherapy Using a Multiparametric MRI-Based Machine Learning Model in Patients With Breast Cancer
Huang, Y., Chen, W., Zhang, X., He, S., Shao, N., Shi, H., Lin, Z., Wu, X., Li, T., Lin, H., et al. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.662749 · Cited by 35
Contrast-Enhanced Mammography Versus MRI in the Evaluation of Neoadjuvant Therapy Response in Patients With Breast Cancer: A Prospective Study
Bernardi, D., Vatteroni, G., Acquaviva, A., Valentini, M., Sabatino, V., Bolengo, I., Pellegrini, M., Fantò, C., & Trimboli, R. M. (2022) · American Journal of Roentgenology · doi:10.2214/ajr.22.27756 · Cited by 35
Predicting Post Neoadjuvant Axillary Response Using a Novel Convolutional Neural Network Algorithm
Ha, R. S., Chang, P., Karcich, J., Mutasa, S., Sant, E. P. V., Connolly, E. P., Chin, C., Taback, B., Liu, M. Z., & Jambawalikar, S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6613-4 · Cited by 33
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis
Virostko, J. M., Hainline, A. E., Kang, H., Arlinghaus, L. R., Abramson, R. G., Barnes, S. L., Blume, J. D., Avery, S., Patt, D. A., Goodgame, B. W., et al. (2017) · Journal of medical imaging · doi:10.1117/1.jmi.5.1.011011 · Cited by 30
ACR Appropriateness Criteria® Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update
Hayward, J. H., Linden, O. E., Lewin, A. A., Weinstein, S. P., Bachorik, A. E., Balija, T. M., Kuzmiak, C. M., Paulis, L. V., Salkowski, L. R., Sanford, M. F., et al. (2023) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2023.02.016 · Cited by 29
Complete response on MR imaging after neoadjuvant chemotherapy in breast cancer patients: Factors of radiologic-pathologic discordance
Choi, W. J., Kim, H. H., Cha, J. H., Shin, H. J., Chae, E. Y., & Yoon, G. Y. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.06.017 · Cited by 29
Performance of Mid-Treatment Breast Ultrasound and Axillary Ultrasound in Predicting Response to Neoadjuvant Chemotherapy by Breast Cancer Subtype
Candelaria, R. P., Bassett, R. L., Symmans, W. F., Ramineni, M., Moulder, S. L., Kuerer, H. M., Thompson, A. M., & Yang, W. T. (2017) · The Oncologist · doi:10.1634/theoncologist.2016-0307 · Cited by 28
How to use magnetic resonance imaging following neoadjuvant chemotherapy in locally advanced breast cancer
Price, E. R., Wong, J., Mukhtar, R. A., Hylton, N. M., & Esserman, L. J. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i7.607 · Cited by 27
Accuracy of MRI for treatment response assessment after taxane- and anthracycline-based neoadjuvant chemotherapy in HER2-negative breast cancer
Charehbili, A., Wasser, M. N. J. M., Smit, V. T. H. B. M., Putter, H., van Leeuwen‐Stok, A. E., Kranenbarg, E. M., Liefers, G., van de Velde, C. J. �., Nortier, J. W. R., & Kroep, J. R. (2014) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2014.07.036 · Cited by 27
Breast MRI and tumour biology predict axillary lymph node response to neoadjuvant chemotherapy for breast cancer
Al-Hattali, S., Vinnicombe, S., Gowdh, N. M., Evans, A. J., Armstrong, S., Adamson, D. J. A., Purdie, C. A., & Macaskill, E. J. (2019) · Cancer Imaging · doi:10.1186/s40644-019-0279-4 · Cited by 27
Dynamic contrast-enhanced (DCE) imaging: state of the art and applications in whole-body imaging
Albano, D., Bruno, F., Agostini, A., Angileri, S. A., Benenati, M., Bicchierai, G., Cellina, M. I., Chianca, V., Cozzi, D., Danti, G., et al. (2021) · Japanese Journal of Radiology · doi:10.1007/s11604-021-01223-4 · Cited by 27
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL
Li, W., Arasu, V. A., Newitt, D. N., Jones, E. F., Wilmes, L. J., Gibbs, J., Kornak, J., Joe, B. N., Esserman, L. J., & Hylton, N. (2016) · Tomography · doi:10.18383/j.tom.2016.00247 · Cited by 27
Comparison of Pathologic Response Evaluation Systems After Neoadjuvant Chemotherapy in Breast Cancers: Correlation With Computer-Aided Diagnosis of MRI Features
Choi, W. J., Kim, H. H., Cha, J. H., Shin, H. J., & Chae, E. Y. (2019) · American Journal of Roentgenology · doi:10.2214/ajr.18.21016 · Cited by 27
Metabolic biomarker signature for predicting the effect of neoadjuvant chemotherapy of breast cancer
Lin, X., Xu, R., Mao, S., Zhang, Y., Dai, Y., Guo, Q., Song, X., Zhang, Q., Li, L., & Chen, Q. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.10.34 · Cited by 27
Survival Outcomes for Patients With Clinical Complete Response After Neoadjuvant Chemotherapy: Is Omitting Surgery an Option?
Özkurt, E., Sakai, T., Wong, S. M., Tükenmez, M., & Golshan, M. A. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07534-1 · Cited by 26
Is Clinical Exam of the Axilla Sufficient to Select Node-Positive Patients Who Downstage After NAC for SLNB? A Comparison of the Accuracy of Clinical Exam Versus MRI
Moo, T.-A. S., Jochelson, M. S., Zabor, E. C., Stempel, M. M., Raiss, M., Mamtani, A., Tadros, A. B., El-Tamer, M. B., & Morrow, M. (2019) · Annals of Surgical Oncology · doi:10.1245/s10434-019-07867-x · Cited by 26
The Role of MRI in Breast Cancer and Breast Conservation Therapy
Washington, I. R., Palm, R. F., White, J. R., Rosenberg, S. A., & Ataya, D. K. (2024) · Cancers · doi:10.3390/cancers16112122 · Cited by 25
Breast MRI phenotype and background parenchymal enhancement may predict tumor response to neoadjuvant endocrine therapy
Hilal, T., Covington, M. F., Kosiorek, H., Zwart, C. M., Ocal, I. T., Pockaj, B. A., Northfelt, D., & Patel, B. (2018) · The Breast Journal · doi:10.1111/tbj.13101 · Cited by 25
Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature
Civil, Y. A., Jonker, L. W., Koerkamp, M. P. M. G., Duvivier, K. M., de Vries, R., Oei, A. L., Slotman, B. J., van der Velde, S., & van den Bongard, H. J. G. D. (2023) · Annals of Surgical Oncology · doi:10.1245/s10434-023-13233-9 · Cited by 26
Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis
Ploumen, R. A. W., de Mooij, C. M., Gommers, S., Keymeulen, K., Smidt, M. L., & van Nijnatten, T. J. A. (2023) · European Radiology · doi:10.1007/s00330-023-09547-7 · Cited by 26
Self-citation
Prediction of breast cancer and axillary positive-node response to neoadjuvant chemotherapy based on multi-parametric magnetic resonance imaging radiomics models
Lin, Y. Y., Wang, J., Li, M., Zhou, C., Hu, Y., Wang, M., & Zhang, X. (2024) · The Breast · doi:10.1016/j.breast.2024.103737 · Cited by 24
Accuracy of contrast-enhanced spectral mammography for estimating residual tumor size after neoadjuvant chemotherapy in patients with breast cancer: a feasibility study
Barra, F. R., de Souza, F. F., Camelo, R. E. F. A., Ribeiro, A. C. D. O., & Farage, L. (2017) · Radiologia Brasileira · doi:10.1590/0100-3984.2016-0029 · Cited by 24
MRI Performance in Detecting pCR After Neoadjuvant Chemotherapy by Molecular Subtype of Breast Cancer
Yu, N., Leung, V. W. Y., & Meterissian, S. H. (2019) · World Journal of Surgery · doi:10.1007/s00268-019-05032-9 · Cited by 23
MRI predictors of tumor-positive margins after breast-conserving surgery
Bahl, M., Baker, J. A., Kinsey, E. N., & Ghate, S. V. (2019) · Clinical Imaging · doi:10.1016/j.clinimag.2019.05.006 · Cited by 21
Quantitative background parenchymal enhancement to predict recurrence after neoadjuvant chemotherapy for breast cancer
Molière, S., Oddou, I., Noblet, V., Veillon, F., & Mathelin, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-55820-5 · Cited by 21
Good correlation does not automatically imply good agreement: The trouble with comparing tumour size by breast MRI versus histopathology
Lobbes, M. B. I., & Nelemans, P. J. (2013) · European Journal of Radiology · doi:10.1016/j.ejrad.2013.08.025 · Cited by 20
Self-citation
Staging Breast Cancer with MRI, the T. A Key Role in the Neoadjuvant Setting
Panico, C., Ferrara, F., Woitek, R., D'Angelo, A. R., Paola, V. D., Bufi, E., Conti, M., Palma, S., Cicero, S. L., Cimino, G., et al. (2022) · Cancers · doi:10.3390/cancers14235786 · Cited by 20
Predictors of mastectomy in breast cancer patients with complete remission of primary tumor after neoadjuvant therapy: A retrospective study
Gentile, D., Martorana, F., Karakatsanis, A., Caruso, F., Caruso, M., Castiglione, G., Grazia, A. D., Pane, F., Rizzo, A. G., Vigneri, P. G., et al. (2024) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2024.108732 · Cited by 20
Magnetic resonance imaging patterns of tumor regression in breast cancer patients after neo-adjuvant chemotherapy, and an analysis of the influencing factors
Li, M., Xu, B., Shao, Y., Liu, H., Du, B., & Yuan, J. (2017) · The Breast Journal · doi:10.1111/tbj.12811 · Cited by 20
Clinical Breast Magnetic Resonance Imaging: Technique, Indications, and Future Applications
Greenwood, H. I., Freimanis, R. I., Carpentier, B. M., & Joe, B. N. (2017) · Seminars in Ultrasound CT and MRI · doi:10.1053/j.sult.2017.07.002 · Cited by 20
Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy
Parissenti, A. M., Guo, B., Pritzker, L. B., Pritzker, K. P. H., Wang, X., Zhu, M., Shepherd, L. E., & Trudeau, M. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3498-9 · Cited by 20
Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients
Hottat, N. A., Badr, D. A., Lecomte, S., Besse‐Hammer, T., Jani, J. C., & Cannie, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-27787-x · Cited by 19
Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements
Hottat, N. A., Badr, D. A., Lecomte, S., Besse‐Hammer, T., Jani, J. C., & Cannie, M. (2022) · European Radiology · doi:10.1007/s00330-021-08462-z · Cited by 18
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials
Graeser, M., Schrading, S., Gluz, O., Strobel, K., Herzog, C., Umutlu, L., Frydrychowicz, A. P., Rjosk-Dendorfer, D., Würstlein, R., Culemann, R., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01413-y · Cited by 18
Association of pharmacokinetic and metabolic parameters derived using simultaneous PET/MRI: Initial findings and impact on response evaluation in breast cancer
Jena, A., Taneja, S., Singh, A., Negi, P., Mehta, S. B., Ahuja, A., Singhal, M. K., & Sarin, R. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.04.013 · Cited by 18
Surgical Planning after Neoadjuvant Treatment in Breast Cancer: A Multimodality Imaging-Based Approach Focused on MRI
Conti, M., Morciano, F., Bufi, E., D'Angelo, A. R., Panico, C., Paola, V. D., Gori, E., Russo, G., Cimino, G., Palma, S., et al. (2023) · Cancers · doi:10.3390/cancers15051439 · Cited by 17
Prediction of pathologic complete response after single-dose MR-guided partial breast irradiation in low-risk breast cancer patients: the ABLATIVE-2 trial—a study protocol
Civil, Y. A., Oei, A. L., Duvivier, K. M., Bijker, N., Meijnen, P., Donkers, L., Verheijen, S., van Kesteren, Z., Palacios, M. A., Schijf, L. J., et al. (2023) · BMC Cancer · doi:10.1186/s12885-023-10910-6 · Cited by 17
Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
Iotti, V., Ragazzi, M., Besutti, G., Marchesi, V., Ravaioli, S., Falco, G., Coiro, S., Bisagni, A., Gasparini, E., Rossi, P. G., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11030435 · Cited by 17
Diagnostic performance of digital breast tomosynthesis for predicting response to neoadjuvant systemic therapy in breast cancer patients: A comparison with magnetic resonance imaging, ultrasound, and full-field digital mammography
Murakami, R., Tani, H., Kumita, S., & Uchiyama, N. (2021) · Acta Radiologica Open · doi:10.1177/20584601211063746 · Cited by 16
ACR Appropriateness Criteria® Imaging of the Axilla
Le‐Petross, H. T., Slanetz, P. J., Lewin, A. A., Bao, J. J., Dibble, E. H., Golshan, M. A., Hayward, J. H., Kubicky, C. D., Leitch, A. M., Newell, M. S., et al. (2022) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2022.02.010 · Cited by 16
Magnetic resonance imaging evaluation of residual tumors in breast cancer after neoadjuvant chemotherapy: surgical implications
Zhou, J., Li, G., Sheng, F., Qiao, P., Zhang, H., & Xing, X.-D. (2015) · Acta Radiologica · doi:10.1177/0284185115597263 · Cited by 16
Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?
Thompson, B. M., Chala, L. F., Shimizu, C., Mano, M. S., Filassi, J. R., Geyer, F. C., Torres, U. S., de Mello, G. G. N., & Leite, C. D. C. (2021) · European Radiology · doi:10.1007/s00330-021-08290-1 · Cited by 16
Prediction of pathological response to neoadjuvant chemotherapy in breast cancer patients by imaging
Kaise, H., Shimizu, F., Akazawa, K., Hasegawa, Y., Horiguchi, J., Miura, D., Kohno, N., & Ishikawa, T. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2017.12.002 · Cited by 16
Contrast-Enhanced Mammography-Guided Biopsy: Preliminary Results of a Single-Center Retrospective Experience
Sammarra, M., Piccolo, C. L., Sarli, M., Stefanucci, R., Tommasiello, M., Orsaria, P., Altomare, V., & Zobel, B. B. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13040933 · Cited by 15
Three-dimensional ultrasonography of the breast; An adequate replacement for MRI in neoadjuvant chemotherapy tumour response evaluation? − RESPONDER trial
van Egdom, L. S. E., Lagendijk, M., Heijkoop, E., Koning, A. H. J., van Deurzen, C. H. M., Jager, A., van Lankeren, W., & Koppert, L. B. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.05.005 · Cited by 15
Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy
Kim, M. J., Kim, E., Park, S., Moon, H. J., Kim, S. U., & Park, B. (2014) · Acta Radiologica · doi:10.1177/0284185114548507 · Cited by 14
Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response
Santamaría, G., Bargalló, X., Ganau, S., Alonso, I., Muñoz-Mateu, M., Mollà, M., Fernandez, P. R., & Prat, A. (2019) · European Journal of Radiology · doi:10.1016/j.ejrad.2019.06.009 · Cited by 14
Breast radiologic complete response is associated with favorable survival outcomes after neoadjuvant chemotherapy in breast cancer
Woo, J., Ryu, J. M., Jung, S. M., Choi, H. J., Lee, S. K., Yu, J., Lee, J. E., Kim, S. W., Nam, S. J., & Chae, B. J. (2020) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2020.08.023 · Cited by 14
Outcome and Cost Effectiveness of Ultrasonographically Guided Surgical Clip Placement for Tumor Localization in Patients undergoing Neo-adjuvant Chemotherapy for Breast Cancer
Masroor, I., Zeeshan, S., Afzal, S., Sufian, S. N., Ali, M. I., Khan, S. M., & Ahmad, K. (2016) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.18.8339 · Cited by 14
The evaluation of the delayed swollen breast in patients with a history of breast implants
Keane, G. C., Keane, A. M., Diederich, R., Kennard, K., Duncavage, E. J., & Myckatyn, T. M. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1174173 · Cited by 13
Oncologic and cosmetic outcomes of oncoplastic breast-conserving surgery after neoadjuvant systemic therapy: systematic review and meta-analysis
Ahmed, G. A., Baron, D. H., & Agrawal, A. (2024) · Breast Cancer Research and Treatment · doi:10.1007/s10549-024-07566-6 · Cited by 13

Authors: Lobbes, M. B. I., Prevos, R., Smidt, M., Tjan-Heijnen, V. C. G., van Goethem, M., Schipper, R., Beets-Tan, R. G., & Wildberger, J. E.
Affiliations: Maastricht University Medical Centre (NL)
Corresponding author: Lobbes, M. B. I.
ORCID: Lobbes, M. B. I.
Smidt, M.
Schipper, R.
Wildberger, J. E.
Venue: Insights into Imaging
Publisher: Springer Science and Business Media LLC
Published: 2013-01-29
Volume: 4
Issue: 2
Pages: 163-175
ISSN: 1869-4101 (ISSN-L)
DOI: 10.1007/s13244-013-0219-y
PMC: PMC3609956
OpenAlex: W2057016707
Cited by: 237
References: 56
Citations by year: 2026: 10 · 2025: 15 · 2024: 27 · 2023: 21 · 2022: 22 · 2021: 25 · 2020: 15 · 2019: 23 · 2018: 16 · 2017: 24 · 2016: 16 · 2015: 11 · 2014: 8 · 2013: 4
FWCI: 1.84
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by-nc/2.0 (unspecified)
Locations: Insights into Imaging (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, cc-by)
Research Publications (Maastricht University) (submittedVersion, cc-by)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: breast MRI, residual disease, pathological complete response, neoadjuvant chemotherapy, invasive breast cancer, diagnostic accuracy, breast cancer subtypes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The role of magnetic resonance imaging in assessing residual disease and pathologic complete response in breast cancer patients receiving neoadjuvant chemotherapy: a systematic review

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks